Presentation is loading. Please wait.

Presentation is loading. Please wait.

Evaluation of the HAS-BLED, ATRIA, and ORBIT Bleeding Risk Scores in Patients with Atrial Fibrillation Taking Warfarin  Keitaro Senoo, MD, Marco Proietti,

Published byHilda Đokić Modified over 5 years ago

Similar presentations

Presentation on theme: "Evaluation of the HAS-BLED, ATRIA, and ORBIT Bleeding Risk Scores in Patients with Atrial Fibrillation Taking Warfarin  Keitaro Senoo, MD, Marco Proietti,"— Presentation transcript:

1 Evaluation of the HAS-BLED, ATRIA, and ORBIT Bleeding Risk Scores in Patients with Atrial Fibrillation Taking Warfarin  Keitaro Senoo, MD, Marco Proietti, MD, Deirdre A. Lane, PhD, Gregory Y.H. Lip, MD  The American Journal of Medicine  Volume 129, Issue 6, Pages (June 2016) DOI: /j.amjmed Copyright © 2016 Elsevier Inc. Terms and Conditions

2 Figure 1 Incidence rate of bleeding outcomes according to HAS-BLED, ATRIA, and ORBIT scores. (A) Any clinically relevant bleeding. (B) Major bleeding. ATRIA = Anticoagulation and Risk Factors in Atrial Fibrillation; HAS-BLED = Hypertension, Abnormal renal/liver function, Stroke, Bleeding history or predisposition, Labile international normalized Ratio, Elderly, Drugs/alcohol; ORBIT = Outcomes Registry for Better Informed Treatment. The American Journal of Medicine  , DOI: ( /j.amjmed ) Copyright © 2016 Elsevier Inc. Terms and Conditions

3 Figure 2 Area under the curve for bleeding end points with the 3 bleeding risk scores. (A) Any clinically relevant bleeding. (B) Major bleeding. ATRIA = Anticoagulation and Risk Factors in Atrial Fibrillation; AUC = area under the curve; CI = confidence interval; HAS-BLED = Hypertension, Abnormal renal/liver function, Stroke, Bleeding history or predisposition, Labile international normalized Ratio, Elderly, Drugs/alcohol; ORBIT = Outcomes Registry for Better Informed Treatment; SE = standard error. The American Journal of Medicine  , DOI: ( /j.amjmed ) Copyright © 2016 Elsevier Inc. Terms and Conditions

4 Figure 3 Any clinically relevant bleeding in relation to tertiles of time to therapeutic range and time in therapeutic range as a continuous variable, by ORBIT and ATRIA scores. (A) Time in therapeutic range by tertiles of time in therapeutic range. (B) Time in therapeutic range as a continuous variable vs ORBIT score. (C) Time in therapeutic range as a continuous variable vs ATRIA score. ATRIA = Anticoagulation and Risk Factors in Atrial Fibrillation; ORBIT = Outcomes Registry for Better Informed Treatment; TTR = time in therapeutic range. The American Journal of Medicine  , DOI: ( /j.amjmed ) Copyright © 2016 Elsevier Inc. Terms and Conditions

Download ppt "Evaluation of the HAS-BLED, ATRIA, and ORBIT Bleeding Risk Scores in Patients with Atrial Fibrillation Taking Warfarin  Keitaro Senoo, MD, Marco Proietti,"

Similar presentations

Low-Dose Aspirin in Patients with Stable Cardiovascular Disease: A Meta-analysis Jeffrey S. Berger, MD, MS, David L. Brown, MD, Richard C. Becker, MD The.

Low-Dose Aspirin in Patients with Stable Cardiovascular Disease: A Meta-analysis Jeffrey S. Berger, MD, MS, David L. Brown, MD, Richard C. Becker, MD The.
Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study  Lars Frost, MD, PhD, Lone Juul Hune,

Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study  Lars Frost, MD, PhD, Lone Juul Hune,
Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated.

Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated.
Anne B. Yates, MD  The American Journal of Medicine 

Anne B. Yates, MD  The American Journal of Medicine 
Paul D. Stein, MD, Fadi Matta, MD, Mary J. Hughes, DO 

Paul D. Stein, MD, Fadi Matta, MD, Mary J. Hughes, DO 
New-onset Atrial Fibrillation Predicts Heart Failure Progression

New-onset Atrial Fibrillation Predicts Heart Failure Progression
The Effect of Smoking on the Risk of Sciatica: A Meta-analysis

The Effect of Smoking on the Risk of Sciatica: A Meta-analysis
Sexuality The American Journal of Medicine

Sexuality The American Journal of Medicine
Renato D. Lopes, MD, PhD, Li Li, MS, Christopher B

Renato D. Lopes, MD, PhD, Li Li, MS, Christopher B
Dabigatran and Warfarin for Secondary Prevention of Stroke in Atrial Fibrillation Patients: A Nationwide Cohort Study  Torben Bjerregaard Larsen, MD,

Dabigatran and Warfarin for Secondary Prevention of Stroke in Atrial Fibrillation Patients: A Nationwide Cohort Study  Torben Bjerregaard Larsen, MD,
An Unusual Cause of Leg Ulcerations

An Unusual Cause of Leg Ulcerations
Antithrombotic Treatment Patterns in Patients with Newly Diagnosed Nonvalvular Atrial Fibrillation: The GLORIA-AF Registry, Phase II  Menno V. Huisman,

Antithrombotic Treatment Patterns in Patients with Newly Diagnosed Nonvalvular Atrial Fibrillation: The GLORIA-AF Registry, Phase II  Menno V. Huisman,
Impact of More Restrictive Blood Transfusion Strategies on Clinical Outcomes: A Meta- analysis and Systematic Review  Shelley R. Salpeter, MD, Jacob S.

Impact of More Restrictive Blood Transfusion Strategies on Clinical Outcomes: A Meta- analysis and Systematic Review  Shelley R. Salpeter, MD, Jacob S.
Volume 137, Issue 2, Pages (February 2010)

Volume 137, Issue 2, Pages (February 2010)
Dabigatran and Warfarin for Secondary Prevention of Stroke in Atrial Fibrillation Patients: A Nationwide Cohort Study  Torben Bjerregaard Larsen, MD,

Dabigatran and Warfarin for Secondary Prevention of Stroke in Atrial Fibrillation Patients: A Nationwide Cohort Study  Torben Bjerregaard Larsen, MD,
Richard V. Milani, MD, Carl J. Lavie, MD, Robert M

Richard V. Milani, MD, Carl J. Lavie, MD, Robert M
Prevalence, Predictors, and Outcomes in Treatment-resistant Hypertension in Patients with Coronary Disease  Sripal Bangalore, MD, MHA, Rana Fayyad, PhD,

Prevalence, Predictors, and Outcomes in Treatment-resistant Hypertension in Patients with Coronary Disease  Sripal Bangalore, MD, MHA, Rana Fayyad, PhD,
Samy Suissa, PhD, Abbas Kezouh, PhD, Pierre Ernst, MD, MSc 

Samy Suissa, PhD, Abbas Kezouh, PhD, Pierre Ernst, MD, MSc 
Phosphorus and Risk of Renal Failure in Subjects with Normal Renal Function  John J. Sim, MD, Simran K. Bhandari, MD, Ning Smith, PhD, Joanie Chung, MS,

Phosphorus and Risk of Renal Failure in Subjects with Normal Renal Function  John J. Sim, MD, Simran K. Bhandari, MD, Ning Smith, PhD, Joanie Chung, MS,
Systematic Review and Meta-analysis of Adverse Events of Low-dose Aspirin and Clopidogrel in Randomized Controlled Trials  Kenneth R. McQuaid, MD, Loren.

Systematic Review and Meta-analysis of Adverse Events of Low-dose Aspirin and Clopidogrel in Randomized Controlled Trials  Kenneth R. McQuaid, MD, Loren.

Similar presentations

Ads by Google